Contradictions in Focus: Navigating Innovation, Tariffs, and China Market Challenges in Q1 2025

None



Revenue and Market Conditions:
- Kenvue reported a 1.2% decline in organic sales in Q1 2025 compared to the previous year.
- The decline was influenced by factors such as destocking in China, strategic investments in price and trade in the US, and seasonal variability in certain product categories.

Regional Performance Variations:
- In the Self Care segment, organic sales grew 0.3%, with growth driven by allergy, digestive health, and smoking cessation franchises, more than offsetting a decline in cough, cold, and flu.
- Skin Health and Beauty saw a 4.8% decline in organic sales, attributed to factors like destocking in China, soft sun seasons in Latin America, and strategic price investments in the US.

Impact of Tariffs and Foreign Exchange:
- Kenvue anticipates a 1% drag on top-line growth from currency, an improvement from the previously assumed 3% impact.
- The company estimates the gross impact of tariffs, including those implemented by the US and retaliatory measures by other countries, to be nearly $150 million for 2025.

Innovation and Brand Investment:
- Kenvue is enhancing its brand presence through innovations and marketing campaigns, such as the successful launch of Neutrogena's Beauty to a Science brand positioning.
- The company plans to continue investing more in brand marketing than the previous year, focusing on returns and value propositions.